Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Cencora

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
From Cencora
Via Business Wire
Tickers COR
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
From Cencora
Via Business Wire
Tickers COR
Cencora Reinforces Efforts to Strengthen Pharmaceutical Supply Chain with Expansion of Drug Shortages Mitigation Program
From Cencora
Via Business Wire
Cencora Reports Fiscal 2025 First Quarter Results
From Cencora
Via Business Wire
Tickers COR
Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
From Cencora
Via Business Wire
Tickers COR
Cencora Completes Acquisition of Retina Consultants of America
From Cencora
Via Business Wire
Tickers COR
Cencora Closes $1.8 Billion Senior Notes Offering
From Cencora
Via Business Wire
Tickers COR
Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers
From Cencora
Via Business Wire
Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035
From Cencora
Via Business Wire
Tickers COR
Cencora to Host Inaugural Product Showcase
From Cencora
Via Business Wire
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
From Cencora
Via Business Wire
Tickers COR
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
From Cencora
Via Business Wire
Tickers COR
Cencora Expands Enterprise Leadership Team with Two Senior Appointments
From Cencora
Via Business Wire
Tickers COR
Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
From Cencora
Via Business Wire
Tickers COR
Cencora Supports Pharmaceutical Supply Chain Education with Two New Programs for Health System Pharmacy Residents
From Cencora
Via Business Wire
Cencora Elects Frank Clyburn to Its Board of Directors
From Cencora
Via Business Wire
Tickers COR
Alcura Obtains Manufacturing and Importation Authorization License, Expanding its Capabilities to Support Cell & Gene Therapy Developers
From Cencora
Via Business Wire
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
From Cencora
Via Business Wire
Tickers COR
Good Neighbor Pharmacy® Named #1 in Customer Satisfaction with Chain Drug Store Pharmacies by J.D. Power for 8th Consecutive Year
From Cencora
Via Business Wire
Cencora Reports Fiscal 2024 Third Quarter Results
From Cencora
Via Business Wire
Tickers COR
Good Neighbor Pharmacy Network Celebrates Independent Community Pharmacy Excellence at ThoughtSpot 2024
From Cencora
Via Business Wire
Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
From Cencora
Via Business Wire
Tickers COR
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
From Cencora
Via Business Wire
Tickers COR
Cencora To Host Inaugural ThinkLive Cell and Gene Therapy Summit
From Cencora
Via Business Wire
Cencora Reports Fiscal 2024 Second Quarter Results
From Cencora
Via Business Wire
Tickers COR
Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
From Cencora
Via Business Wire
Tickers COR
Cencora Announces Leadership Succession Plan
From Cencora
Via Business Wire
Tickers COR
Cencora’s FormularyDecisions Launches Payer Resource for Cell and Gene Therapy Products
From Cencora
Via Business Wire
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
From Cencora
Via Business Wire
Tickers COR
Cencora Closes $500 Million Senior Notes Offering
From Cencora
Via Business Wire
Tickers COR
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.